Xydalba

dalbavancin hydrochloride · AbbVie Deutschland GmbH & Co. KG

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Xydalba, covering 2025-11-20 to 2025-11-20. Get the full timeline:

Most recent: EMA Authorised: Xydalba (dalbavancin hydrochloride) — AbbVie Deutschland GmbH & Co. KG